ВІЗИРИН

Przegląd produktu

About ВІЗИРИН

ВІЗИРИН is a medication that contains the active ingredient Irinotecan, which is used in the treatment of certain types of cancer. It belongs to a class of drugs known as topoisomerase I inhibitors, which work by interfering with the growth and spread of cancer cells. ВІЗИРИН is specifically designed to target and kill cancer cells, helping to slow down or stop the progression of the disease.

Key Benefits & Uses

• Treatment of colorectal cancer
• Treatment of small cell lung cancer
• Palliative care to relieve symptoms and improve quality of life

Active Ingredient & Action

Irinotecan, the active ingredient in ВІЗИРИН, works by inhibiting the enzyme topoisomerase I, which is essential for DNA replication and cell division. By blocking this enzyme, Irinotecan prevents cancer cells from growing and multiplying, ultimately leading to cell death. This mechanism of action helps to reduce tumor size and slow down disease progression.

Important Notes

ВІЗИРИН should only be used under the guidance of a qualified healthcare professional. Patients should follow the prescribed dosage and administration schedule carefully, and report any side effects or concerns to their doctor. It is also important to note that ВІЗИРИН may interact with other medications, and patients should inform their doctor about all medications they are currently taking.